Crinetics Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
Provided By GlobeNewswire
Last update: Nov 12, 2024
Submission of New Drug Application for Paltusotine for the Treatment of Acromegaly
Completed Upsized Public Offering of $575M of Common Stock
Read more at globenewswire.com
